VOYA Investment Management’s Mersana Therapeutics MRSN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-10,123
| Closed | -$3.48K | – | 2712 |
|
2025
Q1 | $3.48K | Sell |
10,123
-26,067
| -72% | -$8.97K | ﹤0.01% | 2635 |
|
2024
Q4 | $51.8K | Sell |
36,190
-2,111
| -6% | -$3.02K | ﹤0.01% | 2679 |
|
2024
Q3 | $72.4K | Sell |
38,301
-287
| -0.7% | -$542 | ﹤0.01% | 2718 |
|
2024
Q2 | $77.6K | Buy |
38,588
+2,061
| +6% | +$4.14K | ﹤0.01% | 2730 |
|
2024
Q1 | $164K | Sell |
36,527
-9,506
| -21% | -$42.6K | ﹤0.01% | 2516 |
|
2023
Q4 | $107K | Buy |
46,033
+2,402
| +6% | +$5.57K | ﹤0.01% | 2741 |
|
2023
Q3 | $55.4K | Sell |
43,631
-13,076
| -23% | -$16.6K | ﹤0.01% | 2842 |
|
2023
Q2 | $187K | Sell |
56,707
-445,452
| -89% | -$1.47M | ﹤0.01% | 2614 |
|
2023
Q1 | $2.06M | Buy |
502,159
+215,265
| +75% | +$885K | ﹤0.01% | 1346 |
|
2022
Q4 | $1.68M | Buy |
286,894
+47,610
| +20% | +$279K | ﹤0.01% | 1402 |
|
2022
Q3 | $1.62M | Buy |
239,284
+206,112
| +621% | +$1.39M | ﹤0.01% | 1411 |
|
2022
Q2 | $153K | Buy |
33,172
+6,846
| +26% | +$31.6K | ﹤0.01% | 2500 |
|
2022
Q1 | $105K | Hold |
26,326
| – | – | ﹤0.01% | 2510 |
|
2021
Q4 | $164K | Sell |
26,326
-112
| -0.4% | -$698 | ﹤0.01% | 2572 |
|
2021
Q3 | $249K | Hold |
26,438
| – | – | ﹤0.01% | 2446 |
|
2021
Q2 | $359K | Buy |
26,438
+3,488
| +15% | +$47.4K | ﹤0.01% | 2287 |
|
2021
Q1 | $371K | Sell |
22,950
-110
| -0.5% | -$1.78K | ﹤0.01% | 2191 |
|
2020
Q4 | $614K | Buy |
23,060
+5,121
| +29% | +$136K | ﹤0.01% | 1786 |
|
2020
Q3 | $334K | Buy |
17,939
+2,023
| +13% | +$37.7K | ﹤0.01% | 1882 |
|
2020
Q2 | $372K | Sell |
15,916
-3,051
| -16% | -$71.3K | ﹤0.01% | 1846 |
|
2020
Q1 | $111K | Hold |
18,967
| – | – | ﹤0.01% | 2316 |
|
2019
Q4 | $109K | Buy |
18,967
+5,898
| +45% | +$33.9K | ﹤0.01% | 2524 |
|
2019
Q3 | $21K | Hold |
13,069
| – | – | ﹤0.01% | 2542 |
|
2019
Q2 | $53K | Buy |
+13,069
| New | +$53K | ﹤0.01% | 2557 |
|